PubMedID: 12611489Thrombotic microangiopathy (TMA) is a syndrome characterized by microangiopathic haemolytic anaemia, thrombocytopenia, and several variable signs of organ damage due to the platelet thrombi in the microcirculation. This article reports a case with TMA which developed after ingestion of a high-dose combination of verapamil and trandolapril. To the authors' knowledge, no prior cases of TMA induced by trandolapril (an angiotensin-converting enzyme inhibitor) and verapamil (a calcium channel blocker) have been reported in the literature
The authors describe a case of very serious thrombocytopenic purpura occurring in a diabetic and hyp...
The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolyti...
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consu...
WOS: 000180619500011PubMed ID: 12611489Thrombotic microangiopathy (TMA) is a syndrome characterized ...
Thrombotic microangiopathy (TMA) is a micro-vascular occlusive disorder characterized by predom-inan...
Abstract Background Thrombotic microangiopathy (TMA) is a serious, sometimes life-threatening disord...
Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important ...
Bevacizumab is a human monoclonal antibody against VEGF. Many adverse reactions about bevacizumab ar...
Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma. We ...
Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic ar...
Copyright © 2013 Federico Cicora et al.This is an open access article distributed under the Creative...
Copyright © 2012 S. Regragui et al. This is an open access article distributed under the Creative Co...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
A 76-year-old male with metastatic renal carcinoma on day 24 of pazopanib was admitted with complain...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
The authors describe a case of very serious thrombocytopenic purpura occurring in a diabetic and hyp...
The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolyti...
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consu...
WOS: 000180619500011PubMed ID: 12611489Thrombotic microangiopathy (TMA) is a syndrome characterized ...
Thrombotic microangiopathy (TMA) is a micro-vascular occlusive disorder characterized by predom-inan...
Abstract Background Thrombotic microangiopathy (TMA) is a serious, sometimes life-threatening disord...
Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important ...
Bevacizumab is a human monoclonal antibody against VEGF. Many adverse reactions about bevacizumab ar...
Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma. We ...
Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic ar...
Copyright © 2013 Federico Cicora et al.This is an open access article distributed under the Creative...
Copyright © 2012 S. Regragui et al. This is an open access article distributed under the Creative Co...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
A 76-year-old male with metastatic renal carcinoma on day 24 of pazopanib was admitted with complain...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
The authors describe a case of very serious thrombocytopenic purpura occurring in a diabetic and hyp...
The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolyti...
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consu...